Jason Wild, a Director and 10% Holder, acquired 2,715 Common Shares on a control or direction basis for registered holder Insight Wellness, 6,336 Common Shares on a control or direction basis for registered holder JW Growth Fund, LLC, 23,925 Common Shares on a control or direction basis for registered holder JW Opportunities Master Fund, Ltd. and 55,824 Common Shares on a control or direction basis for registered holder JW Partners, LP at a price of US$6.22 on December 2nd, 2021. This represents a $707,762 investment into the company's shares and an account share holdings change of 0.1%.
TerrAscend is in the Pharmaceuticals Sub Industry Group under the Healthcare Sector.
TerrAscend Corp. (TerrAscend) is a Canada-based company that operates a chain of Apothecarium dispensary retail locations, as well as scaled cultivation, processing, and manufacturing facilities on both the East and West coasts of the United States. The Company's cultivation and manufacturing practices provide product selection to both the medical and legal adult-use market. TerrAscend operates a range of synergistic businesses, including The Apothecarium (Apothecarium); Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ilera Healthcare (Ilera), Pennsylvania's medical cannabis cultivator, processor and dispenser; HMS Health, LLC and HMS Processing, LLC, a medical cannabis cultivator and processor based in Maryland; Valhalla Confections, a manufacturer of cannabis-infused edibles, and State Flower a California-based cannabis producer operating a licensed cultivation facility in San Francisco. TerrAscend Corp. (TER) has a high amount of executive buying compared to its mid-cap peers in the market over the past three months. According to recent regulatory filings, one insider has invested a total amount of $707,762.
No Comments